The WSJ reports that Sanofi-Aventis SA is expected to acquire Genzyme Corp. (GENZ) for about $19 billion in cash, plus possible additional payments in the future, in a deal that could be announced as soon as Wednesday.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply